The DOI matches its Crossref record.
Polymeric Micelles for Delivery of Poorly Water-Soluble Compounds
Abstract
Amphiphilic polymers assemble into nanoscopic supramolecular core-shell structures, termed polymeric micelles, which are under extensive study for drug delivery. There are several reasons for this growing interest. Polymeric micelles maybe safe for parenteral administration relative to existing solubilizing agents (for instance, Cremophor EL), permitting an increase in the dose of potent yet toxic and poorly water soluble compounds. Polymeric micelles solubilize important poorly water-soluble compounds, such as amphotericin B (AmB), propofol, paclitaxel, and photosensitizers. A major factor in drug solubilization is the compatibility of a drug and a core of a polymeric micelle. In this context, we may consider Pluronics, poly(ethylene glycol) (PEG)-phospholipid conjugates, PEG-b-poly(ester)s, and PEG-b-poly(L-amino acid)s for drug delivery. Polymeric micelles may circulate for prolonged periods in blood, evade host defenses, and gradually release drug. Thus, they may show a preferential accumulation at sites of disease such as solid tumors. Polymeric micelles inhibit p-glycoprotein at drug-resistant tumors, gastrointestinal tract, and blood/brain barrier, perhaps providing a way to overcome drug resistance in cancer and increase drug absorption from the gut and drug absorption into the brain. Lastly, polymeric micelles may reduce the self-aggregation of polyene antibiotics, key membrane-acting drugs used to combat life-threatening systemic fungal diseases. In this way, they may reduce its dose-limiting toxicity without a loss of antifungal activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The major benefit of polyester over other polymers is that a wide range of polyesters was approved for biomedical usage, such as poly(lactic acid) (PLA), poly(ε-caprolactone) (PCL), poly(propylene oxide) (PPO), poly(trimethylene carbonate) (PTMC), and poly(lactic-co-glycolic acid) (PLGA) [69].”
From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [69]
Citations
Cited by
Sorted by citations
Items 101–200 of 502
Shah, T. J., Amin, A. F., Parikh, J. R., & Parikh, R. H. (2007) · AAPS PharmSciTech · doi:10.1208/pt0802029 · Cited by 105
In Vitro Evaluation of Theranostic Polymeric Micelles for Imaging and Drug Delivery in Cancer
Kumar, R., Kulkarni, A., Nagesha, D. K., & Sridhar, S. (2012) · Theranostics · doi:10.7150/thno.3927 · Cited by 103
“[27, 28] Highly fluorescent QDs are generally synthesized with hydrophobic ligands and for biological applications have to be converted to hydrophilic particles.”
BackgroundHu, F., Meng, P., Dai, Y.-Q., Du, Y., You, J., Wei, X.-H., & Yuan, H. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.06.015 · Cited by 104
Sugar-Based Amphiphilic Polymers for Biomedical Applications: From Nanocarriers to Therapeutics
Gu, L., Faig, A., Abdelhamid, D. S., & Uhrich, K. E. (2014) · Accounts of Chemical Research · doi:10.1021/ar4003009 · Cited by 101
Ultrasound-Mediated Local Drug and Gene Delivery Using Nanocarriers
Zhou, Q.-L., Chen, Z., Wáng, Y. X. J., Yang, F., Lin, Y., & Liao, Y. (2014) · BioMed Research International · doi:10.1155/2014/963891 · Cited by 99
“Polymericmicelles such as PEO-PPO block copolymers are safer and kinetically stable and have higher solubilization capacity than the regular micelles [72, 73].”
BackgroundShen, Y., Zhan, Y., Tang, J., Xu, P., Johnson, P. A., Radosz, M., Kirk, E. A. V., & Murdoch, W. J. (2008) · AIChE Journal · doi:10.1002/aic.11600 · Cited by 97
Star polymer-based unimolecular micelles and their application in bio-imaging and diagnosis
Jin, X., Sun, P., Tong, G., & Zhu, X. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.051 · Cited by 97
“As mentioned above, polymeric micelles formed by self-assembly of linear amphiphilic block copolymers have attracted significant attention due to their unique core-shell micellar structures, which enable them to be excellent candidates for biomedical applications [64, 65, 78].”
BackgroundMethodYe, W.-L., Zhao, Y.-P., Li, H.-Q., Na, R., Li, F., Mei, Q., Zhao, M., & Zhou, S.-Y. (2015) · Scientific Reports · doi:10.1038/srep14614 · Cited by 96
Polymeric nanomedicines for poorly soluble drugs in oral delivery systems: an update
Ma, X., & Williams, R. O. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0372-2 · Cited by 95
“As reported, polymeric micelles will have a lower CMC when the system is more hydrophobic, consisting of a large hydrophobic portion (Astafieva et al. 1993; Kwon 2003).”
BackgroundPatel, S., Lavasanifar, A., & Choi, P. (2008) · Biomacromolecules · doi:10.1021/bm800320z · Cited by 92
pH-Responsive Nanoparticles for Cancer Drug Delivery
Shen, Y., Tang, H., Radosz, M., Kirk, E. V., & Murdoch, W. J. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-210-6_10 · Cited by 93
Modern Micro and Nanoparticle-Based Imaging Techniques
Ryvolová, M., Chomoucká, J., Drbohlavová, J., Kopel, P., Babula, P., Hynek, D., Adam, V., Eckschlager, T., Hubálek, J., Stiborová, M., et al. (2012) · Sensors · doi:10.3390/s121114792 · Cited by 91
“The majority of anticancer therapeutics is water insoluble and need to be dissolved in an organic solvent that is usually toxic [165].”
BackgroundThermosensitive Y‐Shaped Micelles of Poly(oleic acid‐Y‐N‐isopropylacrylamide) for Drug Delivery
Li, Y., Zhang, X., Kim, G., Cheng, H. L., Cheng, S., & Zhuo, R. (2006) · Small · doi:10.1002/smll.200600041 · Cited by 90
Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer
Yang, H., Tang, C., & Yin, C. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.04.020 · Cited by 89
Degradable Poly(β-amino ester) nanoparticles for cancer cytoplasmic drug delivery
Shen, Y., Tang, H., Zhan, Y., Kirk, E. A. V., & Murdoch, W. J. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.09.003 · Cited by 89
Abd-Elsalam, W. H., El‐Zahaby, S. A., & Al-mahallawi, A. M. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1436098 · Cited by 88
“The systems are characterized by their superior solubilizing capacity when compared with the regular micelles owing to their larger cores (Kwon, 2003).”
BackgroundProtein nanoparticles directed cancer imaging and therapy
Miao, Y., Yang, T., Yang, S., Yang, M., & Mao, C. (2022) · Nano Convergence · doi:10.1186/s40580-021-00293-4 · Cited by 90
“Also, many anti-cancer drugs are insoluble or slightly soluble in water, which increases the difficulty of drug delivery [23].”
BackgroundPluronic F127-Based Thermosensitive Gels for Delivery of Therapeutic Proteins and Peptides
Akash, M. S. H., Rehman, K., & Chen, S. (2014) · Journal of macromolecular science. Part C, Reviews in macromolecular chemistry and physics/Journal of macromolecular science. Reviews in macromolecular chemistry and physics · doi:10.1080/15583724.2014.927885 · Cited by 88
Gold Nanoparticles for Brain Tumor Imaging: A Systematic Review
Meola, A., Rao, J., Chaudhary, N., Sharma, M., & Chang, S. D. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00328 · Cited by 89
“First, PEG reduces GNPs clearance by the reticuloendothelial system and improves the exposure of the organs to GNPs (18); second, by reducing the reticuloendothelial clearance, PEG promotes GNPs accumulation in the brain tumor (55); third, PEG reduces potential intravascular aggregation of GNPs (aka “stealth effect”);…”
BackgroundRey‐Rico, A., & Cucchiarini, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030775 · Cited by 91
Chen, M., Tsai, H.-W., Liu, C.-T., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.047 · Cited by 86
“Differing from other hydrophobic-particle-embedded hydrogel systems [19–21], these micelles can provide nanoscopic supramolecular core–shell architectures wherein the hydrophobic core serves as a cargo space for the encapsulation of poorly soluble drugs and the hydrophilic shell allows nanoparticles homogeneously disp…”
BackgroundPolymer Micelles as Drug Carriers
Batrakova, E. V., Bronich, T. K., Vetro, J. A., & Kabanov, A. V. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781860949074_0005 · Cited by 94
Yu, Y., Chen, D., Li, Y., Yang, W., Tu, J., & Shen, Y. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1458923 · Cited by 85
“Typically, micelles are formed around a hydrophobic drug in aqueous solution because of the orientation of surfactant molecules to form a hydrophobic core enclosing the drug within a hydrophilic shell (Allen et al., 1999; Kwon, 2003).”
BackgroundZhu, S., Lansakara-P, D. S. P., Li, X., & Cui, Z. (2012) · Bioconjugate Chemistry · doi:10.1021/bc2005945 · Cited by 85
Transport mechanisms of mmePEG750P(CL-co-TMC) polymeric micelles across the intestinal barrier
Mathot, F., Rieux, A. D., Ariën, A., Schneider, Y., Brewster, M. E., & Véronique Préat, A. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.001 · Cited by 84
Stable loading and delivery of disulfiram with mPEG-PLGA/PCL mixed nanoparticles for tumor therapy
Song, W., Tang, Z., Tian, L., Wen, X., Wang, G., Zhang, D., Deng, M., Tang, X., & Chen, X. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.10.022 · Cited by 84
Block copolymers at interfaces: Interactions with physiological media
Torcello‐Gómez, A., Wulff-Pérez, M., Gálvez-Ruiz, M. J., Martín-Rodríguez, A., Cabrerizo-Vílchez, M. Á., & Maldonado‐Valderrama, J. (2013) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2013.10.027 · Cited by 83
Zhang, Y., Jin, T., & Zhuo, R. (2005) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2005.06.004 · Cited by 80
Disposition of Drugs in Block Copolymer Micelle Delivery Systems
Aliabadi, H. M., Shahin, M., Brocks, D. R., & Lavasanifar, A. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847100-00001 · Cited by 78
Mechanism for Development of Nanobased Drug Delivery System
Pathak, C., Vaidya, F. U., & Pandey, S. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814029-1.00003-x · Cited by 89
Liu, L., Yong, K., Roy, I., et al. (2012) · Theranostics · doi:10.7150/thno.3456 · Cited by 77
“gene carriers [24-32].”
Encapsulation of a Hydrophobic Drug into a Polymer-Micelle Core Explored with Synchrotron SAXS
Akiba, I., Terada, N., Hashida, S., Sakurai, K., Sato, T., Shiraishi, K., Yokoyama, M., Masunaga, H., Ogawa, H., Ito, K., et al. (2010) · Langmuir · doi:10.1021/la904355p · Cited by 76
Li, Y., Zhang, X., Cheng, H. L., Kim, G., Cheng, S., & Zhuo, R. (2006) · Biomacromolecules · doi:10.1021/bm060080k · Cited by 75
Hu, R., Law, W., Lin, G., et al. (2012) · Theranostics · doi:10.7150/thno.4275 · Cited by 76
“They have been used as nanocarriers in encapsulating hydrophobic molecules for many biomedical applications [8, 9].”
BackgroundFairley, N., Hoang, B., & Allen, C. (2008) · Biomacromolecules · doi:10.1021/bm800572p · Cited by 75
Steinhauer, W., Hoogenboom, R., Keul, H., & Möller, M. (2013) · Macromolecules · doi:10.1021/ma302606x · Cited by 75
Huynh, V. T., Quek, J. Y., de Souza, P. L., & Stenzel, M. H. (2012) · Biomacromolecules · doi:10.1021/bm2017299 · Cited by 73
Mondon, K., Labouebe, M. Z., Gurny, R., & Möller, M. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.09.012 · Cited by 76
“These values in the micro molar range are in agreement with data reported in the literature [30,4].”
BackgroundResultPEGylated nanostructured lipid carriers (PEG–NLC) as a novel drug delivery system for biochanin A
Wang, L., Luo, Q., Lin, T., Li, R., Zhu, T., Zhou, K., Ji, Z., Song, J.-W., Jia, B., Zhang, C., et al. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2014.938082 · Cited by 74
Polymeric micelles for potentiated antiulcer and anticancer activities of naringin
Mohamed, E. A., Hashim, I. I. A., Yusif, R. M., Shaaban, A. A., El‐Sheakh, A. R., Hamed, M. F., & Badria, F. A.-E. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s154325 · Cited by 74
“38 In the light of the abovementioned facts, it was worth to prepare, characterize, and optimize polymeric micellar delivery systems of naringin with the relatively inexpensive and biocompatible pluronic F68 (PF68).”
Yin, H., & Bae, Y. H. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.013 · Cited by 72
Azum, N., Rub, M. A., & Asiri, A. M. (2017) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2017.1283510 · Cited by 71
Zheng, S., Han, J., Jin, Z., Kim, C., Park, S., Kim, K., Park, J.-O., & Choi, E. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.02.005 · Cited by 71
Self-assembled elastin-like polypeptide particles
Osborne, J. L., Farmer, R. S., & Woodhouse, K. A. (2007) · Acta Biomaterialia · doi:10.1016/j.actbio.2007.07.007 · Cited by 70
The effect of core composition in biodegradable oligomeric micelles as taxane formulations
Carstens, M. G. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.014 · Cited by 69
“Comparable results were obtained with Pluronics (PEG-b-polypropyleneoxide (PPO)-b-PEG) [12] and PEG–PLA micelles above the glass transition temperature of PLA [45].”
BackgroundResultLee, J., Termsarasab, U., Lee, M., Kim, D., Lee, S., Kim, J. S., Cho, H.-J., & Kim, D.-D. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.05.012 · Cited by 59
Block copolymer micelles as a solution for drug delivery problems
Torchilin, V. P. (2005) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.15.1.63 · Cited by 69
“A number of good recent reviews exist dealing with various aspects of polymeric micelle preparation, physicochemical and biological properties, and possible applications as pharmaceutical carriers [24-26,38-44].”
Bioactive nanotherapeutic trends to combat triple negative breast cancer
Chowdhury, P., Ghosh, U., Samanta, K., Jaggi, M., Chauhan, S. C., & Yallapu, M. M. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.02.037 · Cited by 70
“The previous issues of poor solubility and low bioavailability of the conventional anticancer drugs have been overcome by nano-formulating them [201].”
BackgroundCopolymers: Efficient Carriers for Intelligent Nanoparticulate Drug Targeting and Gene Therapy
Hamidi, M., Shahbazi, M., & Rostamizadeh, K. (2011) · Macromolecular Bioscience · doi:10.1002/mabi.201100193 · Cited by 66
Li, X., Li, P., Zhang, Y., Zhou, Y., Chen, X., Huang, Y., & Liu, Y. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0147-1 · Cited by 65
“Micelles with blocks made of poly(ethylene oxide) are sterically stabilized and undergo less opsonization and uptake by the macrophages of the reticuloendothelial system (RES), allowing the micelles to circulate longer in blood ( 27 ,28).”
BackgroundInfluentialPegylated Phospholipids-Based Self-Assembly with Water-Soluble Drugs
Wang, Y., Wang, R. L., Lu, X., Lü, W.-L., Zhang, C., & Liang, W. P. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-0029-6 · Cited by 64
“Polymeric micelles are currently used as nanoscale carriers for poorly soluble drugs ( 2 ,3).”
BackgroundSemiconductor Quantum Dots as Two-Photon Sensitizers
Dayal, S., & Burda, C. (2008) · Journal of the American Chemical Society · doi:10.1021/ja0781285 · Cited by 63
Nano-Oncology: Clinical Application for Cancer Therapy and Future Perspectives
Riggio, C., Pagni, E., Raffa, V., & Cuschieri, A. (2011) · Journal of Nanomaterials · doi:10.1155/2011/164506 · Cited by 63
Novel pH-sensitive chitosan-derived micelles loaded with paclitaxel
Liu, J., Li, H., Jiang, X., et al. (2010) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2010.04.084 · Cited by 62
Akiyama, M., Ikeda, A., Shintani, T., Doi, Y., Kikuchi, J., Ogawa, T., Yogo, K., Takeya, T., & Yamamoto, N. (2008) · Organic & Biomolecular Chemistry · doi:10.1039/b719671g · Cited by 62
Sutton, D. M., Wang, S., Nasongkla, N., Gao, J., & Dormidontova, E. E. (2007) · Experimental Biology and Medicine · doi:10.3181/0702-rm-31 · Cited by 62
Nanostructure-based drug delivery systems for brain targeting
Haque, S., Md, S., Alam, M. I., Sahni, J. K., Ali, J., & Baboota, S. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.608191 · Cited by 62
Tao, L., & Uhrich, K. E. (2006) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2005.12.018 · Cited by 59
Capretto, L., Cheng, W., Carugo, D., et al. (2012) · Nanotechnology · doi:10.1088/0957-4484/23/37/375602 · Cited by 59
Mechanistic Investigation of Pluronic® Based Nano-crystalline Drug-polymer Solid Dispersions
Qian, F., Tao, J., Desikan, S., et al. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9275-7 · Cited by 59
Gold Nanoparticles for Photothermally Controlled Drug Release
Guerrero, A. R., Hassan, N., Escobar, C. A., Alberício, F., Kogan, M. J., & Araya, E. (2014) · Nanomedicine · doi:10.2217/nnm.14.126 · Cited by 59
Temperature Dependence of Poloxamer Insertion Into and Squeeze-Out from Lipid Monolayers
Frey, S. L., & Lee, K. Y. C. (2007) · Langmuir · doi:10.1021/la0626398 · Cited by 59
Biodegradable polymeric nanostructures in therapeutic applications: opportunities and challenges
Shukla, S. K., Shukla, S. K., Govender, P. P., & Giri, N. G. (2016) · RSC Advances · doi:10.1039/c6ra15764e · Cited by 61
Cancer Detection and Treatment: The Role of Nanomedicines
LaRocque, J., Bharali, D. J., & Mousa, S. A. (2009) · Molecular Biotechnology · doi:10.1007/s12033-009-9161-0 · Cited by 58
“[29].”
Xie, Y., Li, G., Yuan, X., et al. (2009) · AAPS PharmSciTech · doi:10.1208/s12249-009-9246-x · Cited by 57
Novel pluronic‐chitosan micelle as an ocular delivery system
Lin, H., & Chang, P. (2013) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.32871 · Cited by 56
“Polymeric micelle formulation is one of the strategies currently used to improve drug absorption and increase ocular bioavailability.(18,19) Pluronic is one of the best known polymers used to prepare the micelles.”
BackgroundHofman, J.-W., Carstens, M. G., van Zeeland, F., Helwig, C., Flesch, F. M., Hennink, W. E., & van Nostrum, C. F. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9590-7 · Cited by 56
“It is anticipated that mPEG750-b-OCL5Bz micelles may act as a stable carrier system for mTHPC in the blood circulation because of its stability in serum and inhibited cellular uptake, allowing their selective accumulation at the tumor site after intravenous administration by the EPR effect (20,21).”
Solubility enhancement of paclitaxel using a linear-dendritic block copolymer
Zhou, Z., D’Emanuele, A., & Attwood, D. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.04.075 · Cited by 58
Mohamed, E. A., Zhao, Y., Meshali, M. M., Remsberg, C. M., Borg, T. M., Foda, A. M. M., Takemoto, J. K., Sayre, C. L., Martinez, S. E., Davies, N. M., et al. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23265 · Cited by 56
“The analytical column used was a Phenomenex Luna C18 (2) (250 × 4.60 mm2, 5:m pore size).”
InfluentialNanomedicines in the future of pediatric therapy
Sosnik, A., & Carcaboso, A. M. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.004 · Cited by 57
Polymeric Nanocarriers: New Endeavors for the Optimization of the Technological Aspects of Drugs
Sosnik, A., Carcaboso, A. M., & Chiappetta, D. A. (2008) · Recent Patents on Biomedical Engineering · doi:10.2174/1874764710801010043 · Cited by 55
“, polyethoxylated castor oil or Cremophor EL, polysorbate 80 or Tween 80), even at concentrations below the CMC, extending their circulation times in blood [97].”
BackgroundAzum, N., Rub, M. A., Asiri, A. M., & Kashmery, H. A. (2018) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2018.03.088 · Cited by 55
Self‐Assembled, Thermosensitive PCL‐g‐P(NIPAAm‐co‐HEMA) Micelles for Drug Delivery
Li, Y., Zhang, X., Cheng, H. L., Zhu, J., Cheng, S., & Zhuo, R. (2006) · Macromolecular Rapid Communications · doi:10.1002/marc.200600521 · Cited by 55
Cheng, C., Wei, H., Zhu, J., Chang, C., Cheng, H. L., Li, C., Cheng, S., Zhang, X., & Zhuo, R. (2008) · Bioconjugate Chemistry · doi:10.1021/bc8000062 · Cited by 54
Sivadasan, D., Sultan, M. H., Madkhali, O. A. A., et al. (2022) · Molecules · doi:10.3390/molecules27031086 · Cited by 53
In vitro and in vivo evaluation of a simple microemulsion formulation for propofol
Li, G., Fan, Y., Li, X., et al. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.01.011 · Cited by 53
Solubilization of an amphiphilic drug by poly(ethylene oxide)-block-poly(ester) micelles
Elhasi, S., Astaneh, R., & Lavasanifar, A. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.12.022 · Cited by 53
Frey, S. L., Zhang, D., Carignano, M. A., et al. (2007) · The Journal of Chemical Physics · doi:10.1063/1.2768947 · Cited by 53
Cooper, D. L., Conder, C. M., & Harirforoosh, S. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.938046 · Cited by 56
“Polymeric micelles can be modified to control the rate of drug release, thus increasing blood circulation time and avoiding host defenses that would target drugs for degradation [62].”
BackgroundOcular delivery systems for topical application of anti-infective agents
Duxfield, L., Sultana, R., Wang, R., Englebretsen, V., Deo, S., Rupenthal, I. D., & Al‐Kassas, R. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2015.1070171 · Cited by 52
Valero, M., & Dreiss, C. A. (2010) · Langmuir · doi:10.1021/la100596q · Cited by 50
Chang, T., Trench, D., Putnam, J., Stenzel, M. H., & Lord, M. S. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00820 · Cited by 51
Polymeric micelle nanoparticles for photodynamic treatment of head and neck cancer cells
Cohen, E. M., Ding, H., Kessinger, C. W., Khemtong, C., Gao, J., & Sumer, B. D. (2010) · Otolaryngology · doi:10.1016/j.otohns.2010.03.032 · Cited by 50
Lamch, Ł., Kulbacka, J., Pietkiewicz, J., Rossowska, J., Dubińska–Magiera, M., Choromańska, A., & Wilk, K. A. (2016) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2016.04.018 · Cited by 47
Jang, E. H., Shim, M. K., Kim, G. L., et al. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119237 · Cited by 47
Revolutionary Impact of Nanodrug Delivery on Neuroscience
Khanbabaie, R., & Jahanshahi, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912804499456 · Cited by 47
Zheng, S., Jin, Z., Han, J., Cho, S., Nguyen, V. D., Ko, S. Y., Park, J.-O., & Park, S. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.03.019 · Cited by 46
Li, Y., Zhang, X., Cheng, H. L., Zhu, J., Li, U.-N., Cheng, S., & Zhuo, R. (2007) · Nanotechnology · doi:10.1088/0957-4484/18/50/505101 · Cited by 46
Capretto, L., Carugo, D., Cheng, W., Hill, M., & Zhang, X. (2011) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2011.01.085 · Cited by 47
Near-Infrared Light-Triggered Polymeric Nanomicelles for Cancer Therapy and Imaging
Li, L., Pang, X., & Liu, G. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00648 · Cited by 45
Bergonzi, M. C., Vasarri, M., Marroncini, G., Barletta, E., & Degl’Innocenti, D. (2020) · Molecules · doi:10.3390/molecules25204707 · Cited by 46
“Based on their constituents, they can inhibit P-glycoprotein at drug-resistant tumors, gastrointestinal tract, and blood/brain barrier, perhaps providing some way to beat drug resistance in cancer and increase drug absorption from the gut and drug absorption into the brain [31].”
BackgroundAdvances in Doxorubicin Chemotherapy: Emerging Polymeric Nanocarriers for Drug Loading and Delivery
Bhadran, A., Polara, H., Babanyinah, G. K., Baburaj, S., & Stefan, M. C. (2025) · Cancers · doi:10.3390/cancers17142303 · Cited by 58
“However, their stability can be affected by dilution, enzymatic degradation, or non-specific interactions with serum components, necessitating careful optimization of polymer chemistry and architecture [190,191].”
Organic Nanocarriers for Delivery and Targeting of Therapeutic Agents for Cancer Treatment
Peng, Y., Bariwal, J. B., Kumar, V., Tan, C., & Mahato, R. I. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900136 · Cited by 44
Zeng, X., Cheng, X., Zheng, Y., Yan, G., Wang, X., Wang, J., & Tang, R. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116139 · Cited by 43
Zeng, F., Liu, J., & Allen, C. J. (2004) · Biomacromolecules · doi:10.1021/bm049836a · Cited by 45
Bony, B. A., Tarudji, A. W., Miller, H. A., Gowrikumar, S., Roy, S., Curtis, E. T., Gee, C. C., Vecchio, A., Dhawan, P., & Kievit, F. M. (2021) · ACS Nano · doi:10.1021/acsnano.1c08432 · Cited by 42
Revolutionary Impact of Nanodrug Delivery on Neuroscience
Khanbabaie, R., & Jahanshahi, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912804143513 · Cited by 44
Mohamed, E. A., Hashim, I. I. A., Yusif, R. M., Suddek, G. M., Shaaban, A. A., & Badria, F. A.-E. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.09.029 · Cited by 41
Invertible Micellar Polymer Assemblies for Delivery of Poorly Water-Soluble Drugs
Hevus, I., Modgil, A., Daniels, J. W., Kohut, A., Sun, C., Stafslien, S. J., & Voronov, A. S. (2012) · Biomacromolecules · doi:10.1021/bm3007924 · Cited by 42
Na, H. S., Lim, Y. K., Jeong, Y., Lee, H. S., Lim, Y. J., Kang, M., Cho, C., & Lee, H. C. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.08.041 · Cited by 41
Metadata
- Authors
- Kwon, G. S.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Kwon, Glen S.
- ORCID
- Kwon, Glen S.
- Venue
- Critical Reviews in Therapeutic Drug Carrier Systems
- Publisher
- Begell House
- Published
- 2003
- Volume
- 20
- Issue
- 5
- Pages
- 357-403
- ISSN
- 0743-4863 (ISSN-L)
- OpenAlex
- W2082105104
- Cited by
- 502
- References
- 0
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 12 · 2023: 15 · 2022: 17 · 2021: 13 · 2020: 20 · 2019: 15 · 2018: 26 · 2017: 28 · 2016: 24 · 2015: 20 · 2014: 28 · 2013: 36 · 2012: 35
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Reviews in Therapeutic Drug Carrier Systems (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI-43346-06)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › Surfactants and Colloidal Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- polymeric micelles, poorly water-soluble drugs, drug solubilization, drug delivery, amphotericin B, propofol, paclitaxel, photosensitizers, poloxamer, tumor targeting, P-glycoprotein inhibition, drug resistance, polyene antibiotics, antifungal agents, parenteral administration
- MeSH terms
- Drug Stability, Pharmaceutical Preparations, Humans, Micelles, Pharmacokinetics, Polyethylene Glycols, Solubility, Surface-Active Agents, Water, Poloxamer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
